STOCK TITAN

[Form 4] US Physical Therapy Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

US Physical Therapy Inc. (USPH) Chief Financial Officer Carey P. Hendrickson reported a disposal of 698 shares of common stock on 08/25/2025 at an average price of $86.11 per share, leaving beneficial ownership of 27,808 shares. The filing shows Mr. Hendrickson is an officer (Chief Financial Officer) and the Form 4 was filed by one reporting person.

The reported holdings include 14,510 shares issued as restricted stock under the companys Amended and Restated 2003 Stock Incentive Plan. Those restricted shares vest in scheduled tranches from November 20, 2025 through March 6, 2029, contingent on continued employment, with specific share counts and vesting dates provided in the filing.

Carey P. Hendrickson, Chief Financial Officer di US Physical Therapy Inc. (USPH), ha comunicato la cessione di 698 azioni ordinarie il 25/08/2025 a un prezzo medio di $86,11 per azione, mantenendo una partecipazione beneficiaria pari a 27.808 azioni. La comunicazione indica che il signor Hendrickson è un dirigente (Chief Financial Officer) e che il Modulo 4 è stato presentato da una sola persona che effettua la segnalazione.

Le partecipazioni riportate includono 14.510 azioni emesse come azioni vincolate ai sensi del piano di incentivazione azionaria Amended and Restated 2003 Stock Incentive Plan della società. Tali azioni vincolate maturano in tranche programmate dal 20 novembre 2025 al 6 marzo 2029, subordinate al mantenimento dell'impiego, con il numero di azioni e le date di maturazione specificate nel deposito.

Carey P. Hendrickson, Director Financiero (CFO) de US Physical Therapy Inc. (USPH), notificó la venta de 698 acciones ordinarias el 25/08/2025 a un precio promedio de $86.11 por acción, quedando con una participación beneficiaria de 27.808 acciones. La presentación indica que el Sr. Hendrickson es un ejecutivo (Chief Financial Officer) y que el Formulario 4 fue presentado por una sola persona informante.

Las tenencias reportadas incluyen 14.510 acciones emitidas como acciones restringidas bajo el Amended and Restated 2003 Stock Incentive Plan de la compañía. Esas acciones restringidas se liberan en tramos programados desde el 20 de noviembre de 2025 hasta el 6 de marzo de 2029, condicionadas a la continuidad del empleo, con los recuentos de acciones y las fechas de vencimiento detalladas en la presentación.

US Physical Therapy Inc.(USPH)의 최고재무책임자(CFO) 케리 P. 헨드릭슨은 2025년 8월 25일 보통주 698주를 주당 평균 $86.11에 처분했으며, 그 결과 실질 소유주로서 27,808주를 보유하고 있습니다. 제출 서류에는 헨드릭슨 씨가 임원(Chief Financial Officer)이며 Form 4가 한 명의 보고자에 의해 제출되었음이 표시되어 있습니다.

보고된 보유분에는 회사의 Amended and Restated 2003 Stock Incentive Plan에 따라 제한부 주식 14,510주가 포함되어 있습니다. 해당 제한부 주식은 고용 유지 조건 하에 2025년 11월 20일부터 2029년 3월 6일까지 예정된 분할 방식으로 베스팅되며, 제출 서류에 각 베스팅 날짜와 주식 수가 명시되어 있습니다.

Carey P. Hendrickson, directeur financier (CFO) de US Physical Therapy Inc. (USPH), a déclaré la cession de 698 actions ordinaires le 25/08/2025 à un prix moyen de 86,11 $ par action, laissant une propriété bénéficiaire de 27 808 actions. Le dépôt indique que M. Hendrickson est un dirigeant (Chief Financial Officer) et que le formulaire 4 a été déposé par une seule personne déclarant.

Les avoirs déclarés incluent 14 510 actions émises en tant qu'actions restreintes dans le cadre du Amended and Restated 2003 Stock Incentive Plan de la société. Ces actions restreintes acquerront des droits par tranches programmées du 20 novembre 2025 au 6 mars 2029, sous réserve du maintien de l'emploi, avec les quantités d'actions et les dates d'acquisition précisées dans le dépôt.

Carey P. Hendrickson, Chief Financial Officer von US Physical Therapy Inc. (USPH), meldete am 25.08.2025 die Veräußerung von 698 Stammaktien zu einem Durchschnittspreis von $86,11 pro Aktie und hält damit weiterhin wirtschaftliches Eigentum an 27.808 Aktien. Die Einreichung weist aus, dass Herr Hendrickson ein leitender Angestellter (Chief Financial Officer) ist und dass das Formular 4 von einer meldenden Person eingereicht wurde.

Die gemeldeten Bestände umfassen 14.510 als Restricted Stock ausgegebene Aktien im Rahmen des Amended and Restated 2003 Stock Incentive Plan des Unternehmens. Diese Restricted Shares werden in geplanten Tranchen vom 20. November 2025 bis zum 6. März 2029 vesten, vorbehaltlich der Fortsetzung des Arbeitsverhältnisses; die Einreichung enthält die genauen Stückzahlen und Vesting-Termine.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: CFO sold a small portion of holdings; substantial restricted stock remains with multi-year vesting schedule.

The 698-share sale at $86.11 is a routine insider disposition representing a small percentage of the CFOs total beneficial ownership of 27,808 shares. The filing discloses that 14,510 of those shares are restricted and vest over 2025-2029, which aligns executive incentive compensation with continued employment. There is no derivative activity disclosed and no indication of accelerated or unusual vesting conditions. For investors, this is a standard Section 16 disclosure of insider activity rather than a material corporate development.

TL;DR: Transaction appears routine and compensation-related; vesting schedule provides retention alignment.

The disclosure shows the company is using time-based restricted stock to retain its CFO, with specific tranche sizes and dates from late 2025 through early 2029. The reported sale is documented and accompanied by full disclosure of remaining beneficial ownership. The filing was executed by an attorney-in-fact, which is common for timely filings. There are no governance red flags, such as accelerated vesting, related-party transactions, or unexplained transfers in this document.

Carey P. Hendrickson, Chief Financial Officer di US Physical Therapy Inc. (USPH), ha comunicato la cessione di 698 azioni ordinarie il 25/08/2025 a un prezzo medio di $86,11 per azione, mantenendo una partecipazione beneficiaria pari a 27.808 azioni. La comunicazione indica che il signor Hendrickson è un dirigente (Chief Financial Officer) e che il Modulo 4 è stato presentato da una sola persona che effettua la segnalazione.

Le partecipazioni riportate includono 14.510 azioni emesse come azioni vincolate ai sensi del piano di incentivazione azionaria Amended and Restated 2003 Stock Incentive Plan della società. Tali azioni vincolate maturano in tranche programmate dal 20 novembre 2025 al 6 marzo 2029, subordinate al mantenimento dell'impiego, con il numero di azioni e le date di maturazione specificate nel deposito.

Carey P. Hendrickson, Director Financiero (CFO) de US Physical Therapy Inc. (USPH), notificó la venta de 698 acciones ordinarias el 25/08/2025 a un precio promedio de $86.11 por acción, quedando con una participación beneficiaria de 27.808 acciones. La presentación indica que el Sr. Hendrickson es un ejecutivo (Chief Financial Officer) y que el Formulario 4 fue presentado por una sola persona informante.

Las tenencias reportadas incluyen 14.510 acciones emitidas como acciones restringidas bajo el Amended and Restated 2003 Stock Incentive Plan de la compañía. Esas acciones restringidas se liberan en tramos programados desde el 20 de noviembre de 2025 hasta el 6 de marzo de 2029, condicionadas a la continuidad del empleo, con los recuentos de acciones y las fechas de vencimiento detalladas en la presentación.

US Physical Therapy Inc.(USPH)의 최고재무책임자(CFO) 케리 P. 헨드릭슨은 2025년 8월 25일 보통주 698주를 주당 평균 $86.11에 처분했으며, 그 결과 실질 소유주로서 27,808주를 보유하고 있습니다. 제출 서류에는 헨드릭슨 씨가 임원(Chief Financial Officer)이며 Form 4가 한 명의 보고자에 의해 제출되었음이 표시되어 있습니다.

보고된 보유분에는 회사의 Amended and Restated 2003 Stock Incentive Plan에 따라 제한부 주식 14,510주가 포함되어 있습니다. 해당 제한부 주식은 고용 유지 조건 하에 2025년 11월 20일부터 2029년 3월 6일까지 예정된 분할 방식으로 베스팅되며, 제출 서류에 각 베스팅 날짜와 주식 수가 명시되어 있습니다.

Carey P. Hendrickson, directeur financier (CFO) de US Physical Therapy Inc. (USPH), a déclaré la cession de 698 actions ordinaires le 25/08/2025 à un prix moyen de 86,11 $ par action, laissant une propriété bénéficiaire de 27 808 actions. Le dépôt indique que M. Hendrickson est un dirigeant (Chief Financial Officer) et que le formulaire 4 a été déposé par une seule personne déclarant.

Les avoirs déclarés incluent 14 510 actions émises en tant qu'actions restreintes dans le cadre du Amended and Restated 2003 Stock Incentive Plan de la société. Ces actions restreintes acquerront des droits par tranches programmées du 20 novembre 2025 au 6 mars 2029, sous réserve du maintien de l'emploi, avec les quantités d'actions et les dates d'acquisition précisées dans le dépôt.

Carey P. Hendrickson, Chief Financial Officer von US Physical Therapy Inc. (USPH), meldete am 25.08.2025 die Veräußerung von 698 Stammaktien zu einem Durchschnittspreis von $86,11 pro Aktie und hält damit weiterhin wirtschaftliches Eigentum an 27.808 Aktien. Die Einreichung weist aus, dass Herr Hendrickson ein leitender Angestellter (Chief Financial Officer) ist und dass das Formular 4 von einer meldenden Person eingereicht wurde.

Die gemeldeten Bestände umfassen 14.510 als Restricted Stock ausgegebene Aktien im Rahmen des Amended and Restated 2003 Stock Incentive Plan des Unternehmens. Diese Restricted Shares werden in geplanten Tranchen vom 20. November 2025 bis zum 6. März 2029 vesten, vorbehaltlich der Fortsetzung des Arbeitsverhältnisses; die Einreichung enthält die genauen Stückzahlen und Vesting-Termine.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HENDRICKSON CAREY P

(Last) (First) (Middle)
1300 W SAM HOUSTON PKWY S
SUITE 300

(Street)
HOUSTON TX 77042

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 S 698 D $86.11 27,808(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 14,510 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,714 shares on November 20, 2025, 1,726 shares on March 6, 2026, 1,246 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,252 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.
/s/ Kate Venturina, as attorney-in-fact 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

When did USPH CFO Carey P. Hendrickson report the transaction?

The transaction date is 08/25/2025 as reported on the Form 4.

How many shares did the reporting person sell and at what price?

698 shares were sold at $86.11 per share according to the filing.

How many USPH shares does Carey P. Hendrickson beneficially own after the reported transaction?

27,808 shares beneficially owned following the transaction.

How many restricted shares are included and what is the vesting schedule?

14,510 restricted shares with vesting tranches from November 20, 2025 through March 6, 2029; specific tranche amounts are listed in the filing.

What is the reporting persons role at USPH?

Carey P. Hendrickson is the Chief Financial Officer and filed the Form 4 as an officer.
U S Physical Therapy

NYSE:USPH

USPH Rankings

USPH Latest News

USPH Latest SEC Filings

USPH Stock Data

1.30B
14.90M
1.97%
105.56%
4.73%
Medical Care Facilities
Services-health Services
Link
United States
HOUSTON